Growth Differentiation Factor-15 as a Candidate Biomarker in Gynecologic Malignancies: A Meta-analysis-Reference-Cited by-同舟云学术

Growth Differentiation Factor-15 as a Candidate Biomarker in Gynecologic Malignancies: A Meta-analysis

Published:2022-10-14 Issue:10 Volume:40 Page:901-910
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Roy Dipayan¹^ORCID,Modi Anupama¹^ORCID,Purohit Purvi¹^ORCID,Khokhar Manoj¹^ORCID,Goyal Manu²^ORCID,Sharma Shailja¹,Setia Puneet³^ORCID,Facciorusso Antonio⁴^ORCID,Sharma Praveen¹^ORCID

Affiliation:

1. Department of Biochemistry, AIIMS, Jodhpur, India

2. Department of Obstetrics & Gynaecology, AIIMS, Jodhpur, India

3. Department of Forensic Medicine & Toxicology, AIIMS, Jodhpur, India

4. Gastroenterology Unit, Department of Medical Sciences, University of Foggia, Foggia, Italy

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2022.2133138

Reference51 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Gynaecological malignancies from palliative care perspective

3. The role of biomarkers in the management of epithelial ovarian cancer

4. GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer

5. Cancer antigen 125 and prognosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of serum Growth Differentiation Factor–15, SMAD7, miRNA-21 & miRNA-181b in pre-diabetics and type 2 diabetics without comorbidities-a case-control study;Aspects of Molecular Medicine;2023-12

2. Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus;Journal of Obesity & Metabolic Syndrome;2023-03-15